Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - levetiracetam 250mg - film coated tablet - 250 mg - active: levetiracetam 250mg excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch opadry blue 85f20694 povidone purified talc - use in epileptic patients aged 6 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 6 years of age with idiopathic generalized epilepsy (ige).

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - levetiracetam 500mg - film coated tablet - 500 mg - active: levetiracetam 500mg excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch opadry yellow 85f32004 povidone purified talc - use in epileptic patients aged 6 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 6 years of age with idiopathic generalized epilepsy (ige).

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - levetiracetam 750mg - film coated tablet - 750 mg - active: levetiracetam 750mg excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch opadry orange 85f23452 povidone purified talc - use in epileptic patients aged 6 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 6 years of age with idiopathic generalized epilepsy (ige).

Australia - inglés - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vetoquinol australia pty ltd - marbofloxacin; clotrimazole; dexamethasone acetate - misc. aural, ophthalmic, oro/naso pharyngeal - marbofloxacin antibiotic active 3.0 mg/ml; clotrimazole imidazole active 10.0 mg/ml; dexamethasone acetate steroid-glucocorticoid active 1.0 mg/ml - ear,nose,throat preps. - dog | bitch | castrate | puppy - otitis externa | acute canine otitis | associated with yeast &/or bac | chronic canine otitis | malassezia pachydermatis | otitis (canine)

Estados Unidos - inglés - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam tablets are indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 4 years of age and older with epilepsy. this product should not be administered to patients who have previously exhibited hypersensitivity to levetiracetam or any of the inactive ingredients in levetiracetam tablets. the abuse and dependence potential of levetiracetam has not been evaluated in human studies.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - levetiracetam -

Australia - inglés - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - levetiracetam -

Australia - inglés - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - levetiracetam -

Australia - inglés - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - levetiracetam -

Australia - inglés - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - levetiracetam -